Quantinno Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-164,330
Closed -$16.2M 2927
2025
Q2
$16.2M Buy
164,330
+76,085
+86% +$7.2M 0.07% 334
2025
Q1
$8.17M Buy
88,245
+28,334
+47% +$2.61M 0.05% 447
2024
Q4
$5.44M Buy
59,911
+19,454
+48% +$1.79M 0.05% 441
2024
Q3
$3.9M Buy
40,457
+15,238
+60% +$1.49M 0.05% 469
2024
Q2
$2.32M Buy
25,219
+970
+4% +$90K 0.04% 522
2024
Q1
$2.23M Buy
24,249
+2,758
+13% +$258K 0.05% 479
2023
Q4
$2.04M Buy
21,491
+5,535
+35% +$517K 0.07% 358
2023
Q3
$1.49M Buy
15,956
+630
+4% +$58.2K 0.07% 394
2023
Q2
$1.4M Buy
+15,326
New +$1.26M 0.08% 319
2020
Q1
Sell
-1,579
Closed -$264K 364
2019
Q4
$264K Sell
1,579
-1,477
-48% -$220K 0.17% 306
2019
Q3
$400K Sell
3,056
-1,189
-28% -$155K 0.27% 163
2019
Q2
$515K Buy
+4,245
New +$504K 0.3% 104
2019
Q1
Sell
-2,601
Closed -$305K 366
2018
Q4
$305K Buy
+2,601
New +$307K 0.25% 188

Other funds holding AMED

Quantinno Capital Management's AMED Position: Q3 2025 in Review

Quantinno Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 164,330 shares — an estimated $16.2M sold.

Quantinno Capital Management first reported a position in AMED in Q4 2018 and held it in 13 quarters. The position peaked at $16.2M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Quantinno Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Quantinno Capital Management sold 164,330 Amedisys shares in Q3 2025, an estimated $16.2M.
  • Quantinno Capital Management first reported a position in Amedisys in Q4 2018 and held it in 13 quarters.
  • Quantinno Capital Management's Amedisys position peaked at $16.2M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Quantinno Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.